Cubist Systematic Strategies, LLC Boston Scientific Corp Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 38,019 shares of BSX stock, worth $3.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,019
Previous 30,231 25.76%
Holding current value
$3.46 Million
Previous $2.33 Million 36.81%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$72.96 - $84.0 $568,212 - $654,192
7,788 Added 25.76%
38,019 $3.19 Million
Q2 2024

Aug 14, 2024
SELL
$67.33 - $77.71 $8.8 Million - $10.2 Million
-130,644 Reduced 81.21%
30,231 $2.33 Million
Q1 2024

May 15, 2024
SELL
$57.6 - $68.62 $1.27 Million - $1.51 Million
-21,983 Reduced 12.02%
160,875 $11 Million
Q4 2023

Feb 14, 2024
BUY
$48.64 - $57.81 $8.89 Million - $10.6 Million
182,858 New
182,858 $10.6 Million
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $29.1 Million - $31.9 Million
584,518 Added 733.25%
664,234 $35.9 Million
Q1 2023

May 15, 2023
BUY
$45.09 - $50.03 $2.74 Million - $3.04 Million
60,764 Added 320.62%
79,716 $3.99 Million
Q4 2022

Feb 14, 2023
SELL
$39.56 - $47.22 $6,804 - $8,121
-172 Reduced 0.9%
18,952 $877,000
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $2.43 Million - $7.26 Million
-66,206 Reduced 77.59%
19,124 $741,000
Q2 2022

Aug 15, 2022
BUY
$35.24 - $47.1 $967,056 - $1.29 Million
27,442 Added 47.41%
85,330 $3.18 Million
Q1 2022

May 16, 2022
BUY
$40.9 - $45.1 $924,708 - $1.02 Million
22,609 Added 64.09%
57,888 $2.56 Million
Q4 2021

Feb 14, 2022
SELL
$38.07 - $44.87 $706,046 - $832,159
-18,546 Reduced 34.46%
35,279 $1.5 Million
Q3 2021

Nov 15, 2021
SELL
$41.23 - $45.88 $12.5 Million - $14 Million
-304,177 Reduced 84.97%
53,825 $2.34 Million
Q2 2021

Aug 16, 2021
BUY
$38.58 - $44.24 $8.99 Million - $10.3 Million
233,125 Added 186.68%
358,002 $15.3 Million
Q1 2021

May 17, 2021
SELL
$35.27 - $39.67 $19.7 Million - $22.1 Million
-558,131 Reduced 81.72%
124,877 $4.83 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $41.97 $4.37 Million - $5.54 Million
131,908 Added 23.94%
683,008 $24.6 Million
Q3 2020

Nov 16, 2020
BUY
$34.44 - $42.23 $16.8 Million - $20.6 Million
488,728 Added 783.57%
551,100 $21.1 Million
Q2 2020

Aug 14, 2020
SELL
$30.19 - $39.11 $6.96 Million - $9.02 Million
-230,559 Reduced 78.71%
62,372 $2.19 Million
Q1 2020

May 15, 2020
BUY
$25.83 - $45.71 $4.16 Million - $7.36 Million
161,062 Added 122.14%
292,931 $9.56 Million
Q4 2019

Feb 14, 2020
SELL
$37.87 - $45.37 $73,695 - $88,290
-1,946 Reduced 1.45%
131,869 $5.96 Million
Q3 2019

Nov 14, 2019
BUY
$40.31 - $43.45 $4.25 Million - $4.58 Million
105,351 Added 370.12%
133,815 $5.45 Million
Q2 2019

Aug 14, 2019
SELL
$34.91 - $42.98 $2.9 Million - $3.57 Million
-83,010 Reduced 74.47%
28,464 $1.22 Million
Q1 2019

May 15, 2019
BUY
$32.91 - $40.75 $3.58 Million - $4.44 Million
108,912 Added 4251.05%
111,474 $4.28 Million
Q4 2018

Feb 14, 2019
SELL
$31.73 - $39.04 $308,066 - $379,039
-9,709 Reduced 79.12%
2,562 $91,000
Q3 2018

Nov 14, 2018
SELL
$32.83 - $38.63 $1.27 Million - $1.5 Million
-38,834 Reduced 75.99%
12,271 $472,000
Q2 2018

Aug 14, 2018
BUY
$26.84 - $34.32 $41,521 - $53,093
1,547 Added 3.12%
51,105 $1.67 Million
Q1 2018

May 15, 2018
SELL
$25.2 - $28.54 $11.5 Million - $13 Million
-457,218 Reduced 90.22%
49,558 $1.35 Million
Q4 2017

Feb 14, 2018
BUY
$24.79 - $29.8 $12.2 Million - $14.7 Million
493,483 Added 3712.35%
506,776 $12.6 Million
Q3 2017

Nov 14, 2017
BUY
$26.26 - $29.17 $349,074 - $387,756
13,293
13,293 $388,000

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email